. 2020 Apr 23;6(6):927–929. doi: 10.1001/jamaoncol.2020.0571

Table. RECIST Objective Responses to Treatment of 32 Patients Evaluable in HERACLES-A².

Best response	No. (%) [95% CI]
RECIST 1.1. by centralized imaging revision
No.	32
Objective response PR + CR%	9 (28) [14-47]
CR	1 (3)
PR	8 (25)
Stable disease, mo
≥4	9 (28) [14-47]
<4	4 (13) [4-29]
Disease control^a	18 (56) [38-74]
Progressive disease	10 (31) [16-50]

Abbreviations: CR, complete response; PR, partial response.

^{^a}

Defined as complete plus partial responses plus stable disease of more than 4 months.

Table. RECIST Objective Responses to Treatment of 32 Patients Evaluable in HERACLES-A2.